tirzepatide surpass-4 versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial Hush Medical Spa

Designed to influence hormones that regulate appetite and metabolism, tirzepatide treatment helps reduce hunger while promoting longer-lasting fullness

Peptide-based approaches tend to have more manageable side effect profiles with temporary adaptation periods, while other compound classes may have more immediate effects but also carry more significant long-term risks

shipping was slow

These medications manage symptoms without interfering with tirzepatide mechanism of action

Cardiovascular Health Tirzepatide may have additional cardiovascular benefits, such as lowering the risk of heart disease, making it an attractive option for individuals concerned about their heart health